{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T05:06:29Z","timestamp":1763787989622,"version":"3.45.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960241"],"award-info":[{"award-number":["81960241"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.imlet.2025.107050","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:23:43Z","timestamp":1749320623000},"page":"107050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["miR-125a-5p regulates Treg function by targeting Foxp3 in experimental autoimmune myasthenia gravis mice"],"prefix":"10.1016","volume":"276","author":[{"given":"Shuting","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinpin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2025.107050_bib0001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"26","key":"10.1016\/j.imlet.2025.107050_bib0002","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.imlet.2025.107050_bib0003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imlet.2025.107050_bib0004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107050_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2018.04.016","article-title":"Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets","volume":"428","author":"Long","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imlet.2025.107050_bib0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jneuroim.2018.05.003","article-title":"Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis","volume":"321","author":"Sabre","year":"2018","journal-title":"J. Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.imlet.2025.107050_bib0007","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2015.06.019","article-title":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients","volume":"356","author":"Punga","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.imlet.2025.107050_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2013.09.014","article-title":"Altered expression of miR-146a in myasthenia gravis","volume":"555","author":"Lu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.imlet.2025.107050_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2016.02.005","article-title":"Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells","volume":"172","author":"Li","year":"2016","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.imlet.2025.107050_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nri3155","article-title":"Selection of regulatory T cells in the thymus","volume":"12","author":"Hsieh","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107050_bib0011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: mechanisms of suppression","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.imlet.2025.107050_bib0012","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107050_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.imlet.2025.107050_bib0014","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imlet.2025.107050_bib0015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12967-023-04427-6","article-title":"MicroRNA-125a-5p regulates the effect of Tregs on Th1 and Th17 through targeting ETS-1\/STAT3 in psoriasis","volume":"21","author":"Yan","year":"2023","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.imlet.2025.107050_bib0016","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4103\/1673-5374.346462","article-title":"Anti-inflammatory effect of miR-125a-5p on experimental optic neuritis by promoting the differentiation of Treg cells","volume":"18","author":"Zhan","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.imlet.2025.107050_bib0017","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor \u03b1-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107050_bib0018","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107050_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2022.09.002","article-title":"Metformin inhibits the pathogenic functions of AChR-specific B and Th17 cells by targeting miR-146a","volume":"250","author":"Hao","year":"2022","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.imlet.2025.107050_bib0020","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11481-013-9498-9","article-title":"Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response","volume":"8","author":"Wang","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107050_bib0021","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","volume":"1412","author":"Cron","year":"2018","journal-title":"Ann. NY Acad. Sci."},{"issue":"4","key":"10.1016\/j.imlet.2025.107050_bib0022","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107050_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.intimp.2019.02.047","article-title":"Triptolide ameliorates lupus via the induction of miR-125a-5p mediating Treg upregulation","volume":"71","author":"Zhao","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.imlet.2025.107050_bib0024","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41590-021-01008-x","article-title":"Restoring control over autoimmunity by inducing Foxp3","volume":"22","author":"Ono","year":"2021","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107050_bib0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2018.01.008","article-title":"Analysis of microRNA expression in the thymus of myasthenia gravis patients opens new research avenues","volume":"17","author":"Cron","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2025.107050_bib0026","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.omtn.2018.09.021","article-title":"miR-125a promotes the progression of giant cell tumors of bone by stimulating IL-17A and \u03b2-catenin expression","volume":"13","author":"Jin","year":"2018","journal-title":"Mol. Ther.-Nucl. Acids"},{"key":"10.1016\/j.imlet.2025.107050_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106404","article-title":"Altered expression of microRNAs may predict therapeutic response in rheumatoid arthritis patients","volume":"83","author":"Rezaeepoor","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107050_bib0028","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1038\/s41598-017-07172-1","article-title":"Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression","volume":"7","author":"Sebastiani","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.imlet.2025.107050_bib0029","article-title":"MiR-125a-5p decreases the sensitivity of Treg cells toward IL-6-mediated conversion by inhibiting IL-6R and STAT3 expression","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.imlet.2025.107050_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2024-000836","article-title":"Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: rationale and design of first-in-human randomised controlled trial","volume":"6","author":"G Brew","year":"2024","journal-title":"BMJ Neurol. Open"},{"issue":"1","key":"10.1016\/j.imlet.2025.107050_bib0031","article-title":"Competing endogenous RNAs network and therapeutic implications: new horizons in disease research","volume":"1868","author":"El-Ashmawy","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA) - Gene Regul. Mech."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T05:03:06Z","timestamp":1763787786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0165247825000835"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107050","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-125a-5p regulates Treg function by targeting Foxp3 in experimental autoimmune myasthenia gravis mice","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107050"}}